Weighing a combination of risk factors could help doctors predict which patients are the most likely to develop atrial fibrillation, a new study suggests.
Read moreBig news today in the world of osteoporosis: A study in the April 28 Archives of Internal Medicine shows that the osteoporosis drug Fosamax... Read more »
The first thing I noticed about atrial fibrillation had nothing to do with my heart or chest. The first thing I noticed was that my lips... Read more »
Our hearts are vital pumps. Just like any pump they work best at the pressures for which they are designed. But unlike most mechanical... Read more »
Katie had an LDL of 87 mg/dl, HDL of 48 mg/dl, triglycerides of 201 mg/dl. By conventional standards, not too bad. Reading about the... Read more »
There's little doubt remaining that omega-3 fatty acids from fish oil reduce dangerous events from heart disease (heart attack and sudden... Read more »
The U.S. Food and Drug Administration has approved the drug Multaq to promote normal heart rhythm in people who suffer from atrial fibrillation or... Read more »
A new study in Italy has found that people's cardiovascular rhythms can "sync" with musical ones. For their experiment, scientists used several... Read more »
A statement from the American Heart Association and the American College of Cardiology are warning health care professionals that certain medications... Read more »
Results of a recent study at Northwestern University show that patients with enlarged hearts demonstrated a 78-percent reduction in mortality rates... Read more »
Two studies have linked the osteoporosis meds Fosamax and Reclast to irregular heart rhythms in a small number of women. The signs of heart problems... Read more »